Myr was predicted to interact with TNF, PTGS2, and MMP9—targets well documented to contribute to lesion persistence, extracellular matrix remodeling, and inflammatory amplification in psoriasis [4,5,32]. The gene discussed is PTGS2; the disease is psoriasis.